Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity

Journal of Pathology

Volumn 226, Issue 1, 2012, Pages 108-119

  Giricz, Orsi ^a   Reynolds, Paul A ^b   Ramnauth, Andrew ^a   Liu, Christina ^a   Wang, Tao ^a   Stead, Lesley ^c   Childs, Geoffrey ^a   Rohan, Thomas ^a   Shapiro, Nella ^c   Fineberg, Susan ^a,c   Kenny, Paraic A ^a   Loudig, Olivier ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

acinar morphogenesis; lobular carcinoma; microRNA

Indexed keywords

HSA MICRORNA 375; MICRORNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CELL; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CARCINOMA IN SITU; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE LOBULAR CARCINOMA; LOBULAR CARCINOMA IN SITU; MORPHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA EXTRACTION; UPREGULATION;

ACINAR CELLS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CELL POLARITY; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; MICRORNAS; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA;

EID: 80655143934     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2978     Document Type: Article

References (49)

1. Biglia N, Mariani L, Sgro L, et al., Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment. Endocr Relat Cancer 2007; 14: 549-567. (Pubitemid 350074047)
2. Wasif N, Maggard MA, Ko CY, et al., Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 2010; 17: 1862-1869.
3. Simpson PT, Reis-Filho JS, Gale T, et al., Molecular evolution of breast cancer. J Pathol 2005; 205: 248-254.
4. Aulmann S, Penzel R, Longerich T, et al., Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 2008; 107: 331-335. (Pubitemid 351172109)
5. Hwang ES, Nyante SJ, Yi Chen Y, et al., Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562-2572. (Pubitemid 38715760)
6. Morandi L, Marucci G, Foschini MP, et al., Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 2006; 449: 14-23. (Pubitemid 43988361)
7. Vos CB, Cleton-Jansen AM, Berx G, et al., E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131-1133. (Pubitemid 27448007)
8. O'Malley FP,. Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol 2010; 23 (Suppl 2): S14-S25.
9. Sullivan ME, Khan SA, Sullu Y, et al., Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med 2010; 134: 1024-1028.
10. Venkitaraman R,. Lobular neoplasia of the breast. Breast J 2010; 16: 519-528.
11. Mastracci TL, Tjan S, Bane AL, et al., E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005; 18: 741-751. (Pubitemid 40780507)
12. Rosen PP,. Microglandular adenosis. A benign lesion simulating invasive mammary carcinoma. Am J Surg Pathol 1983; 7: 137-144. (Pubitemid 13127292)
13. Rakha EA, Ellis IO,. Lobular breast carcinoma and its variants. Semin Diagn Pathol 2010; 27: 49-61.
14. Calin GA, Sevignani C, Dumitru CD, et al., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004; 101: 2999-3004. (Pubitemid 38327724)
15. Sotiropoulou G, Pampalakis G, Lianidou E, et al., Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009; 15: 1443-1461.
16. Zeng Y,. Principles of micro-RNA production and maturation. Oncogene 2006; 25: 6156-6162. (Pubitemid 44527845)
17. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20. (Pubitemid 40094598)
18. Zhang B, Pan X, Cobb GP, et al., microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12. (Pubitemid 46096921)
19. Heneghan HM, Miller N, Lowery AJ, et al., MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009; 2009: 950201.
20. Loudig O, Milova E, Brandwein-Gensler M, et al., Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT). Nucleic Acids Res 2007; 35: e94.
21. Chen J, Lozach J, Garcia EW, et al., Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res 2008; 36: e87.
22. Jorgensen S, Baker A, Moller S, et al., Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 2010; 52: 375-381.
23. Selvin S,. Statistical Analysis for Epidemiologic Data (2nd edn). Oxford University Press: New York, 1996; 228.
24. Debnath J, Muthuswamy SK, Brugge JS,. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003; 30: 256-268. (Pubitemid 36677560)
25. Neter J, Wasserman W,. Applied Linear Statistical Models: Regression, Analysis of variance, and Experimental Design. Richard D Irwin, Inc: Homewood, IL, 1974; 319.
26. Li H, Kloosterman W, Fekete DM,. MicroRNA-183 family members regulate sensorineural fates in the inner ear. J Neurosci 2010; 30: 3254-3263.
27. Poy MN, Eliasson L, Krutzfeldt J, et al., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432: 226-230. (Pubitemid 39545853)
28. Poy MN, Hausser J, Trajkovski M, et al., miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A 2009; 106: 5813-5818.
29. de Souza Rocha Simonini P, Breiling A, Gupta N, et al., Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010; 70: 9175-9184.
30. Debnath J, Brugge JS,. Modelling glandular epithelial cancers in three-dimensional cultures. Nature Rev Cancer 2005; 5: 675-688. (Pubitemid 41486361)
31. Iorio MV, Croce CM,. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856.
32. Hannafon BN, Sebastiani P, de Las Morenas A, et al., Expression of microRNAs and their gene targets are dysregulated in pre-invasive breast cancer. Breast Cancer Res 2011; 13: R24.
33. Guttilla IK, White BA,. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009; 284: 23204-23216.
34. Turashvili G, Bouchal J, Baumforth K, et al., Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection of microarray analysis. BMC Cancer 2007; 7: 55.
35. Segura MF, Hanniford D, Menendez S, et al., Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 2009; 106: 1814-1819.
36. Schaefer A, Jung M, Mollekopf HJ, et al., Diagnostic and prognostic implications of microRNA profiling in prostate cancer. Int J Cancer 2010; 126: 166-176.
37. Sarver AL, French AJ, Borralho PM, et al., Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009; 9: 401.
38. Sacheli R, Nguyen L, Borgs L, et al., Expression patterns of miR-96, miR-182 and miR-183 in the development inner ear. Gene Expr Patterns 2009; 9: 364-370.
39. Ding L, Xu Y, Zhang W, et al., MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010; 20: 784-793.
40. Tsukamoto Y, Nakada C, Noguchi T, et al., MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 2010; 70: 2339-2349.
41. Avissar M, Christensen BC, Kelsey KT, et al., MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 2850-2855.
42. Ladeiro Y, Couchy G, Balabaud C, et al., MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47: 1955-1963. (Pubitemid 351952843)
43. Liu AM, Poon RT, Luk JM,. MicroRNA-375 targets hippo-signalling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010; 394: 623.
44. Zhang H, Mishra A, Chintagari NR, et al., Micro-RNA-375 inhibits lung surfactant secretion by altering cytoskeleton reorganization. IUBMB Life 2010; 62: 78-83.
45. Reis-Filho JS, Simpson PT, Turner NC, et al., FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res 2006; 12: 6652-6662. (Pubitemid 44876833)
46. Riggins RB, Lan JP, Zhu Y, et al., ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res 2008; 68: 8908-8917.
47. Bodian CA, Perzin KH, Lattes R,. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer 1996; 78: 1024-1034. (Pubitemid 26284867)
48. Silvera SA, Rohan TE,. Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence. Breast Cancer Res Treat 2008; 110: 397-409. (Pubitemid 351962587)
49. Kabat GC, Jones JG, Olson N, et al., Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study. Cancer Epidemiol 2010; 34: 34-39.